HR

HR Transformation: MES's Journey to a People-Centric Organization

Retrieved on: 
Monday, September 16, 2024

COLUMBUS, Ohio , Sept. 16, 2024 /PRNewswire-PRWeb/ -- It's been a little more than 8 years since Heena Shah came to MES as Chief People Officer. Since then, MES has grown exponentially with a reach that spans 9 countries and includes hundreds of team members in 20+ cities around the world.

Key Points: 
  • Over the past eight years, Shah has led HR initiatives across nine countries, fostering a positive and engaging work environment for hundreds of team members.
  • Watching the success of our employees and their passion for being here fulfills my goals as MES's Chief People Officer."
  • Being responsible for all aspects of human resources across such a widespread and fast-paced organization as MES is no easy job.
  • Her passion, focus, dedication, and ability to create a people-first organization is evident across the organization and around the world.

How accent bias can impact a person’s job prospects

Retrieved on: 
Sunday, September 15, 2024

This experience can be even more challenging if you’re new to a country and speak with what is perceived to be a “foreign” accent.

Key Points: 
  • This experience can be even more challenging if you’re new to a country and speak with what is perceived to be a “foreign” accent.
  • An accent can often impact how we are viewed and judged by others.
  • At a time when more newcomers are coming to Canada and looking for jobs, it’s important to gain a deeper understanding of accent bias.

Accents and bias

  • People notice accents readily, even though they generally have little difficulty understanding accented speakers.
  • Accents provide listeners with information about speakers, such as where they come from or what other languages they speak.
  • However, accents can also be a source of listener bias.
  • Accent bias also comes with negative consequences for a person’s well-being, including increased stress and poorer mental health.

Research on HR

  • We began our three-phase research by interviewing 14 HR students, six HR instructors and 16 HR professionals in two Canadian cities, Calgary and Montréal, to hear their perspectives on accent bias.
  • We asked 80 HR students from Calgary and Montréal to listen to recordings of simulated job interview responses.
  • Despite research that often points to bias against applicants whose resumes and speech mark them as newcomers, the HR students in our study could easily distinguish between the more and less qualified candidates regardless of language background.

Sharing session

  • Considering that second language speakers express concerns about speaking with an accent and that HR students and professionals desire accent bias training, we conducted a sharing session that brought together recent newcomers to Canada and current HR professionals to grapple with accent bias.
  • Participants were asked to confront myths about accents, such as those that portray accented speakers as unwilling to integrate into the Canadian workplace.

Accents in the real world

Adela Announces Clinical Validation Results for Head & Neck Cancer MRD Test Simultaneously Published in Annals of Oncology and Presented at ESMO 2024

Retrieved on: 
Saturday, September 14, 2024

FOSTER CITY, Calif., Sept. 14, 2024 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular residual disease (MRD) monitoring and early cancer detection through a proprietary genome-wide methylome enrichment technology, has successfully completed clinical validation of its MRD test to predict and surveil for recurrence in head & neck cancer. Results have been published in Annals of Oncology1 and are being presented during an Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2024. 

Key Points: 
  • Results have been published in Annals of Oncology 1 and are being presented during an Oral Presentation at the European Society for Medical Oncology (ESMO) Congress 2024.
  • "Blood-based MRD testing has the potential to transform recurrence monitoring for patients with head & neck cancer.
  • Currently, the majority of recurrences are not detected until symptoms or physical findings are reported by the patient2.
  • "The clinical validation results from Adela's MRD test demonstrate that the test identified recurrences up to 14.9 months earlier than standard of care clinical exam and imaging."

Latest Data of InnoCare’s Orelabrutinib Presented at the European Society for Medical Oncology (ESMO) Congress 2024

Retrieved on: 
Friday, September 13, 2024

Latest data of InnoCare’s (HKEX: 09969; SSE: 688428) orelabrutinib were presented at the European Society for Medical Oncology (ESMO) Congress 2024.

Key Points: 
  • Latest data of InnoCare’s (HKEX: 09969; SSE: 688428) orelabrutinib were presented at the European Society for Medical Oncology (ESMO) Congress 2024.
  • A Prospective Study of Orelabrutinib plus Obinutuzumab (O2) in Treatment-naïve Marginal Zone Lymphoma (MZL): Preliminary Analysis on Efficacy and Safety (Abstract No.
  • The preliminary data demonstrated that the combination of orelabrutinib plus obinutuzumab shows promise in treatment-naive MZL.
  • Among the different orelabrutinib-based regimens, HR was achieved in 100% of patients receiving orelabrutinib monotherapy and 85.7% of those receiving orelabrutinib + chemotherapy.

PURERED EXPANDS EXECUTIVE TEAM WITH NEW PRESIDENT AND NEW EVP OF HR

Retrieved on: 
Friday, September 13, 2024

ATLANTA, Sept. 13, 2024 /PRNewswire/ -- Today, leading advertising, marketing and technology partner, PureRed, announced an expansion of its executive team with the promotion of Heather Collins to President and the hire of Mark Pringle as EVP of HR.

Key Points: 
  • ATLANTA, Sept. 13, 2024 /PRNewswire/ -- Today, leading advertising, marketing and technology partner, PureRed , announced an expansion of its executive team with the promotion of Heather Collins to President and the hire of Mark Pringle as EVP of HR.
  • PureRed names Heather Collins as President and Mark Pringle as Executive Vice President of Human Resources.
  • Cohen also tapped Pringle to serve as Executive Vice President of Human Resources to accelerate the organization's talent and cultural initiatives.
  • He will serve as a strategic advisor to the executive team while optimizing organizational structures and embedding PureRed's core values throughout the company.

Woolpert Welcomes CHRO Specializing in Growth, Employee Engagement, Organizational Development

Retrieved on: 
Friday, September 13, 2024

DAYTON, Ohio, Sept. 13, 2024 /PRNewswire-PRWeb/ -- Woolpert has hired Laura Woolford as chief human resources officer. Woolford has more than 25 years of global HR experience, providing strategic leadership in talent acquisition, employee engagement, diversity and inclusion initiatives, and organizational development. She is based in Austin, Texas.

Key Points: 
  • DAYTON, Ohio, Sept. 13, 2024 /PRNewswire-PRWeb/ -- Woolpert has hired Laura Woolford as chief human resources officer.
  • Woolford has more than 25 years of global HR experience, providing strategic leadership in talent acquisition, employee engagement, diversity and inclusion initiatives, and organizational development.
  • "Over the last decade, Woolpert has grown exponentially—in size, global footprint, and scope of services," Woolford said.
  • In her senior leadership role at Woolpert, Woolford will oversee human resources strategy, including talent acquisition and development, performance management, and employee relations.

Marengo Therapeutics Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Invikafusp alfa (STAR0602) and Trodelvy® in both Metastatic TNBC and Metastatic HR+/HER2- Breast Cancers

Retrieved on: 
Friday, September 13, 2024

This study will evaluate the safety, tolerability, and preliminary efficacy of STAR0602 (Invikafusp alfa) in combination with Trodelvy in patients with metastatic TNBC or metastatic HR+/HER2- breast cancer, aiming to explore a novel therapeutic strategy that could offer new treatment options for patients.

Key Points: 
  • This study will evaluate the safety, tolerability, and preliminary efficacy of STAR0602 (Invikafusp alfa) in combination with Trodelvy in patients with metastatic TNBC or metastatic HR+/HER2- breast cancer, aiming to explore a novel therapeutic strategy that could offer new treatment options for patients.
  • Under the clinical study collaboration and supply agreement, Gilead will provide Trodelvy to Marengo, who will conduct and sponsor the combination study.
  • Marengo and Gilead will retain all development and commercial rights to their respective compounds, including as monotherapy or as combination therapies.
  • The combination of invikafusp alfa and sacituzumab govitecan-hziy is investigational and not approved by any health authority globally.

ISG Names Women in Digital Award EMEA Winners

Retrieved on: 
Friday, September 13, 2024

Information Services Group ( ISG ) (Nasdaq: III ), a leading global technology research and advisory firm, announced the winners of the second annual ISG Women in Digital Awards program for the Europe, Middle East and Africa (EMEA) region, recognizing women and their achievements in the digital world.

Key Points: 
  • Information Services Group ( ISG ) (Nasdaq: III ), a leading global technology research and advisory firm, announced the winners of the second annual ISG Women in Digital Awards program for the Europe, Middle East and Africa (EMEA) region, recognizing women and their achievements in the digital world.
  • “Congratulations to each of the finalists, luminaries and winners of the 2024 ISG Women in Digital Awards,” said Steve Hall, partner and president, ISG EMEA.
  • “Each woman nominated for the ISG Women in Digital Awards EMEA has demonstrated remarkable talent, resilience and vision, and it is an honor to celebrate their accomplishments,” said Kimberly Tobias, ISG director and head of the ISG Women in Digital program.
  • In addition to the ISG Women in Digital Awards, the community hosts a LinkedIn page , ISG Digital Dish webcasts and events for ISG employees and the greater IT and business services industry.

McLean & Company Announces CHRO and DEI Panel Discussions to Take Place at McLean Signature 2024, the Industry Event for Future-Focused HR Professionals

Retrieved on: 
Thursday, September 12, 2024

McLean & Company, the global HR research and advisory firm and host of the McLean Signature 2024 conference, has shared details surrounding the highly anticipated CHRO and DEI panel discussions, details of which can be found in the McLean Signature 2024 conference agenda .

Key Points: 
  • McLean & Company, the global HR research and advisory firm and host of the McLean Signature 2024 conference, has shared details surrounding the highly anticipated CHRO and DEI panel discussions, details of which can be found in the McLean Signature 2024 conference agenda .
  • McLean & Company has created two panel discussions to address two of the HR industry's trending topics for conference attendees, as seen below.
  • The CHRO panel discussion will be moderated by Karen Mann , Senior Vice President of HR Research, Learning & Advisory Services, at McLean & Company.
  • For the full conference agenda or to register for conference tickets, please visit the official Signature event page .

Findem and HireBrain Partner to Help Companies Hire with Unmatched Predictability and Precision

Retrieved on: 
Thursday, September 12, 2024

SAN FRANCISCO, Sept. 12, 2024 /PRNewswire-PRWeb/ -- Findem, the only AI talent acquisition and management solution powered by unique 3D data, together with HireBrain, a hiring enablement platform rooted in neuroscience and powered by generative AI, are introducing an integrated solution that combines the power of intake intelligence with AI-driven talent search and engagement – all resulting in a hiring strategy that drives real business impact.

Key Points: 
  • The integrated solution begins with HireBrain Intake, an AI Assistant for Zoom and Microsoft Teams offering a seamless and consistent intake experience for hiring managers and recruiters.
  • Tailored to meet an organization's specific needs, HireBrain provides a structured format for meetings ensuring recruiters collect essential business intelligence.
  • With one click, HireBrain drafts a Pro-SocialTM job description that aligns to business goals and improves the likelihood of the new hire's success.
  • To ensure privacy, Findem vectorizes all inputs and does not share personally identifiable information with public large language models.